Declaration of interests
AIDS, CLC
AIDS, POLIOMYELITIS
GlaxoSmithKline (GSK) awarded grant funding to Wits VIDA for research related to PCVs. Furthermore, GSK and Pfizer have funded Wits VIDA to undertake non-pneumococcal research. However, neither Pfizer nor GSK contributed to the funding of this study. JRD has received grants from the Poliomyelitis Research Foundation, consultation fees from the international AIDS Vaccine Initiative, and payment from Sanofi-Aventis South Africa and Sci Mentum for work not related to this manuscript. CPO has received grants from Pfizer and the Bill & Melinda Gates Foundation, payment from Sanofi-Aventis South Africa, and support from the Gates Foundation to attend a meeting unrelated to this work. SAM has received grants from Pfizer, Minervax, GSK, the Gates Foundation, and the South African Medical Research Council, and he has received honoraria and support to attend a meeting from GSK and MSD unrelated to this work. CLC has received grants from Sanofi and Duetsche Gesellschaft fur Internationale Zusammenarbeit. All other authors declare no competing interests.